Companies: 48,874 Total Market Cap: 132272321759288.11

GSK plc

NYSE: GSK
Healthcare Drug Manufacturers - General
Rank #267
Market Cap 75.09 B
Volume 7.22 M
Price 37.64
Change (%) 0.19%
Country or region United Kingdom United Kingdom

GSK plc's latest marketcap:

75.09 B

As of 05/17/2025, GSK plc's market capitalization has reached $75.09 B. According to our data, GSK plc is the 267th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 75.09 B
Revenue (ttm) 40.74 B
Net Income (ttm) 4.07 B
Shares Out 4.08 B
EPS (ttm) 0.98
Forward PE 8.10
Ex-Dividend Date 05/16/2025
Earnings Date 04/30/2025
Market Cap Chart
Data Updated: 05/17/2025

GSK plc's yearly market capitalization.

GSK plc has seen its market value grow from $66.80 B to $75.09 B since 2020, representing a total increase of 12.41% and an annual compound growth rate (CAGR) of 2.71%.
Date Market Cap Change (%)
05/17/2025 $75.09 B 3.83%
12/31/2024 $54.94 B -7.05%
12/29/2023 $59.11 B 1.25%
12/30/2022 $58.38 B -27.44%
12/31/2021 $80.46 B 20.44%
12/31/2020 $66.80 B

Company Profile

About GSK plc

GSK plc, together with its subsidiaries, is a global healthcare company specializing in the research, development, and manufacturing of vaccines and medicines to prevent and treat diseases. Headquartered in London, United Kingdom, GSK operates internationally with a strong presence in the UK and the US.

Business Segments

  • Commercial Operations – Focuses on the distribution and sales of vaccines and medicines.
  • Total R&D – Drives innovation through research and development of new treatments and vaccines.

Key Products

  • Vaccines: Shingles, meningitis, respiratory syncytial virus (RSV), infectious diseases, polio, influenza, and pandemic vaccines.
  • Specialty Medicines: Treatments for HIV, oncology, respiratory/immunology, and inflammatory conditions.
  • General Medicines: Inhaled therapies for asthma and COPD, as well as antibiotics for infections.

Strategic Collaborations

  • Partnership with CureVac to develop vaccines for influenza and COVID-19.
  • Collaboration with Flagship Pioneering to discover novel medicines and vaccines.

Company Background

Originally founded in 1715 as GlaxoSmithKline plc, the company rebranded to GSK plc in May 2022. With a legacy spanning over three centuries, GSK remains a leader in global healthcare innovation.

Frequently Asked Questions

As of 05/17/2025, GSK plc (including the parent company, if applicable) has an estimated market capitalization of $75.09 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

GSK plc global market capitalization ranking is approximately 267 as of 05/17/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United Kingdom
Founded 1715
IPO Date n/a
Employees 68,629
CEO Emma Walmsley
Sector Healthcare
Industry Drug Manufacturers - General
Address 79 New Oxford Street
London, WC1A 1DG
United Kingdom
Website https://www.gsk.com
People Also Watch
Eli Lilly
757.39 0.19%
JNJ
151.33 0.19%
AbbVie
184.02 0.19%
Novo Nordisk
64.37 0.19%